Grim milestone: New Jersey surpasses 1 million cases of COVID-19
State health officials report that the state has seen 1,000,067 total positive PCR tests since March 4, 2020.
•
Sep 28, 2021, 8:58 PM
•
Updated 1,032 days ago
Share:
More Stories
0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
31ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
309ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
316ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
316ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
319ds ago0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
31ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
309ds agoMurphy administration: No plans to implement any COVID-19 restrictions
316ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
316ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
319ds agoNew Jersey has officially surpassed 1 million cases of COVID-19.
State health officials report that the state has seen 1,000,067 total positive PCR tests since March 4, 2020. The state reported 1,857 new positive PCR tests on Tuesday.
The good news is that the rate of transmission of the virus is below 1. New Jersey hasn’t consistently stayed below 1 since July. Hospitalizations remain over 1,000, with 1,067 COVID-19 patients reported on Tuesday.
MORE: Search for a Cure
COVID RESOURCES: COVID-19 vaccine resources and case data
Health officials say that there are now over 5.8 million New Jersey residents who are fully vaccinated against the virus.
Pfizer, meanwhile, has submitted its vaccine data to the Food and Drug Administration for children age 5-11. That data is under initial review. The company is expected to submit a formal request for emergency use authorization for children in the next few weeks.
Pfizer is also testing a new antiviral pill that could fight the early stages of COVID-19 after a diagnosis. The pill could even prevent symptoms and limit transmission to people in a patient’s household. Two other antiviral medications are also being tested in clinical trials.
